Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis

Kimiko Kuroki, Naoyuki Tsuchiya, Mitsunori Shiroishi, Linda Rasubala, Yumi Yamashita, Kunio Matsuta, Toru Fukazawa, Makio Kusaoi, Yoshinori Murakami, Masafumi Takiguchi, Takeo Juji, Hiroshi Hashimoto, Daisuke Kohda, Katsumi Maenaka, Katsushi Tokunaga

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5′ portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3′ portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.

Original languageEnglish
Pages (from-to)2469-2480
Number of pages12
JournalHuman Molecular Genetics
Volume14
Issue number16
DOIs
Publication statusPublished - Aug 15 2005

Fingerprint

HLA-DRB1 Chains
Epitopes
Rheumatoid Arthritis
Haplotypes
Leukocytes
Systemic Lupus Erythematosus
Ligands
Cytomegalovirus
Genetic Promoter Regions
Single Nucleotide Polymorphism
Immunoglobulins
Monocytes
Odds Ratio
Lymphocytes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Kuroki, K., Tsuchiya, N., Shiroishi, M., Rasubala, L., Yamashita, Y., Matsuta, K., ... Tokunaga, K. (2005). Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Human Molecular Genetics, 14(16), 2469-2480. https://doi.org/10.1093/hmg/ddi247

Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. / Kuroki, Kimiko; Tsuchiya, Naoyuki; Shiroishi, Mitsunori; Rasubala, Linda; Yamashita, Yumi; Matsuta, Kunio; Fukazawa, Toru; Kusaoi, Makio; Murakami, Yoshinori; Takiguchi, Masafumi; Juji, Takeo; Hashimoto, Hiroshi; Kohda, Daisuke; Maenaka, Katsumi; Tokunaga, Katsushi.

In: Human Molecular Genetics, Vol. 14, No. 16, 15.08.2005, p. 2469-2480.

Research output: Contribution to journalArticle

Kuroki, K, Tsuchiya, N, Shiroishi, M, Rasubala, L, Yamashita, Y, Matsuta, K, Fukazawa, T, Kusaoi, M, Murakami, Y, Takiguchi, M, Juji, T, Hashimoto, H, Kohda, D, Maenaka, K & Tokunaga, K 2005, 'Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis', Human Molecular Genetics, vol. 14, no. 16, pp. 2469-2480. https://doi.org/10.1093/hmg/ddi247
Kuroki, Kimiko ; Tsuchiya, Naoyuki ; Shiroishi, Mitsunori ; Rasubala, Linda ; Yamashita, Yumi ; Matsuta, Kunio ; Fukazawa, Toru ; Kusaoi, Makio ; Murakami, Yoshinori ; Takiguchi, Masafumi ; Juji, Takeo ; Hashimoto, Hiroshi ; Kohda, Daisuke ; Maenaka, Katsumi ; Tokunaga, Katsushi. / Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. In: Human Molecular Genetics. 2005 ; Vol. 14, No. 16. pp. 2469-2480.
@article{ffd74d39f23b425485b86c2674754258,
title = "Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis",
abstract = "Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5′ portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3′ portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.",
author = "Kimiko Kuroki and Naoyuki Tsuchiya and Mitsunori Shiroishi and Linda Rasubala and Yumi Yamashita and Kunio Matsuta and Toru Fukazawa and Makio Kusaoi and Yoshinori Murakami and Masafumi Takiguchi and Takeo Juji and Hiroshi Hashimoto and Daisuke Kohda and Katsumi Maenaka and Katsushi Tokunaga",
year = "2005",
month = "8",
day = "15",
doi = "10.1093/hmg/ddi247",
language = "English",
volume = "14",
pages = "2469--2480",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "16",

}

TY - JOUR

T1 - Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis

AU - Kuroki, Kimiko

AU - Tsuchiya, Naoyuki

AU - Shiroishi, Mitsunori

AU - Rasubala, Linda

AU - Yamashita, Yumi

AU - Matsuta, Kunio

AU - Fukazawa, Toru

AU - Kusaoi, Makio

AU - Murakami, Yoshinori

AU - Takiguchi, Masafumi

AU - Juji, Takeo

AU - Hashimoto, Hiroshi

AU - Kohda, Daisuke

AU - Maenaka, Katsumi

AU - Tokunaga, Katsushi

PY - 2005/8/15

Y1 - 2005/8/15

N2 - Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5′ portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3′ portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.

AB - Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5′ portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3′ portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.

UR - http://www.scopus.com/inward/record.url?scp=26444459466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26444459466&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddi247

DO - 10.1093/hmg/ddi247

M3 - Article

C2 - 16014635

AN - SCOPUS:26444459466

VL - 14

SP - 2469

EP - 2480

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 16

ER -